Spots Global Cancer Trial Database for immunohistochemistry
Every month we try and update this database with for immunohistochemistry cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer | NCT03986541 | Colorectal Canc... | Immunohistochem... | 18 Years - | University of Leeds | |
| Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome | NCT05257057 | Lynch Syndrome Endometrial Can... Endometrial Hyp... Mismatch Repair... Microsatellite ... | Immunohistochem... | 18 Years - 99 Years | WellSpan Health | |
| A Vaccine Study for High Risk Cancers | NCT00944580 | Neuroblastoma Rhabdomyosarcom... Osteogenic Sarc... | MAGE-A1, MAGE-A... | 1 Year - 70 Years | Penn State University | |
| Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma | NCT05889481 | Uveal Melanoma | cytogenetic ana... Digital Patholo... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer | NCT04669951 | Esophagus Cance... | uPAR immunohist... | 18 Years - | Rigshospitalet, Denmark | |
| Immune Resistance Interrogation Study | NCT04243720 | Cancer Solid Tumor Metastatic Canc... Immune Resistan... | 18 Years - | University Health Network, Toronto | ||
| Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC) | NCT01902953 | Colon Cancer Rectal Cancer | Lymphoseek and ... | 18 Years - 85 Years | Maimonides Medical Center | |
| Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development | NCT00340522 | Cancer | - 25 Years | National Institutes of Health Clinical Center (CC) | ||
| Investigation Of Receptivity Markers For Endometrial Cancer Treatment Development | NCT05914844 | Endometrial Can... | - | Celal Bayar University | ||
| Fibrotic Focus in Breast Cancer | NCT04122131 | Breast Cancer | Immunohistochem... | 18 Years - | Chinese University of Hong Kong | |
| Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients | NCT02010047 | Nonsmall Cell L... | ALK qPCR assay | 19 Years - | British Columbia Cancer Agency | |
| Investigation of Desmoplastic Squamous Cell Carcinoma | NCT02717936 | Squamous Cell C... | Immunohistochem... | 18 Years - | University Hospital Tuebingen | |
| Protein Kinase A in Prostate Cancer Tissue. | NCT05460312 | Prostate Neopla... Inflammation Benign Hyperpla... | prostate biopsy | 50 Years - | Ziv Hospital | |
| Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy. | NCT05832593 | Laryngeal Squam... | Immunohistochem... | - | Assiut University | |
| Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer | NCT00900523 | Ovarian Cancer | protein express... immunohistochem... | 17 Years - | Vanderbilt-Ingram Cancer Center | |
| Smurf2 Gene Expression in Urinary Tract Tumors | NCT05134623 | Bladder Neoplas... | immunohistochem... | 18 Years - | Ziv Hospital | |
| Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors. | NCT04283773 | Ovarian Neoplas... Germ Cell Tumor... Immunohistochem... | p16INK4a Recomb... Ki67 antibody (... | 6 Months - 1 Year | Assiut University | |
| Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL) | NCT04300101 | Diffuse Large B... | molecular chara... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Investigation Of Receptivity Markers For Endometrial Cancer Treatment Development | NCT05914844 | Endometrial Can... | - | Celal Bayar University | ||
| Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit | NCT05557474 | Lung Cancer Surgery Recurrence | Early-stage lun... Early-stage lun... | 20 Years - | Chung Shan Medical University | |
| Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL) | NCT04300101 | Diffuse Large B... | molecular chara... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Analysis of Tissues From Patients in Trial of Myo-Inositol to Prevent Lung Cancer | NCT00342836 | AKT | Akt levels | 40 Years - 74 Years | National Institutes of Health Clinical Center (CC) | |
| Immunohistochemical Expression of Inhibin Beta A (INHBA) in Colorectal Carcinoma | NCT05794737 | Colorectal Canc... | Immunohistochem... | 35 Years - 90 Years | Sohag University | |
| GLUT1: A Novel Tool re fl Ecting Proliferative Activity of Lung Neuroendocrine Tumors | NCT03645915 | Lung Tumor | Immunohistochem... | - | Centre Hospitalier Universitaire, Amiens | |
| Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL) | NCT04300101 | Diffuse Large B... | molecular chara... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| PRAME Immunohistochemistry as an Adjunct for Evaluating Ambiguous Melanocytic Proliferation | NCT05089188 | Melanoma | Immunomarkers | 18 Years - | University Hospital, Strasbourg, France | |
| Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer | NCT06147960 | Cancer of Cervi... Apoptosis | Immunohistochem... | 18 Years - | Centre Hospitalier Universitaire de Nīmes | |
| Prognostic Value of PD-L1 in NSCLC | NCT03078959 | Carcinoma, Non-... | immunohistochem... | 18 Years - | Fondazione Ricerca Traslazionale | |
| A Prospective Epidemiologic Study of ALK-Positive NSCLC in China | NCT02042105 | Non-small-cell ... | 18 Years - | Guangdong Association of Clinical Trials | ||
| A Pilot Study on ALK Gene Mutations in Neuroblastoma | NCT01986595 | Neuroblastoma | - 50 Years | National Taiwan University Hospital | ||
| Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy. | NCT05832593 | Laryngeal Squam... | Immunohistochem... | - | Assiut University | |
| Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME) | NCT06007989 | Myeloma | 18 Years - | The Christie NHS Foundation Trust | ||
| Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate Cancers | NCT03961737 | Prostate Cancer | prostate biopsi... | 18 Years - | Institut Cancerologie de l'Ouest | |
| Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma | NCT05889481 | Uveal Melanoma | cytogenetic ana... Digital Patholo... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients With Pancreatic Cancer | NCT03820921 | Pancreatic Canc... | EUS-FNB Immunohistochem... | 18 Years - 90 Years | Ponderas Academic Hospital | |
| Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer | NCT00363454 | Cancer | Triciribine Pho... | 18 Years - | Prescient Therapeutics, Ltd. | |
| Investigation of Desmoplastic Squamous Cell Carcinoma | NCT02717936 | Squamous Cell C... | Immunohistochem... | 18 Years - | University Hospital Tuebingen | |
| p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management | NCT02522585 | Cervical Cancer | Conservative ma... | 18 Years - | Parc de Salut Mar | |
| Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome | NCT05257057 | Lynch Syndrome Endometrial Can... Endometrial Hyp... Mismatch Repair... Microsatellite ... | Immunohistochem... | 18 Years - 99 Years | WellSpan Health | |
| A Pilot Study on ALK Gene Mutations in Neuroblastoma | NCT01986595 | Neuroblastoma | - 50 Years | National Taiwan University Hospital | ||
| Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma | NCT05553080 | Cancer of Colon | Immunohistochem... | 30 Years - 90 Years | Sohag University | |
| Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer | NCT03047226 | Lynch Syndrome | next-generation... | - | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| A Vaccine Study for High Risk Cancers | NCT00944580 | Neuroblastoma Rhabdomyosarcom... Osteogenic Sarc... | MAGE-A1, MAGE-A... | 1 Year - 70 Years | Penn State University | |
| Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development | NCT00340522 | Cancer | - 25 Years | National Institutes of Health Clinical Center (CC) | ||
| Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME) | NCT06007989 | Myeloma | 18 Years - | The Christie NHS Foundation Trust | ||
| Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma | NCT04031534 | Squamous Cell C... | F-Miso PET scan... | 18 Years - | Centre Henri Becquerel | |
| Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions | NCT03920800 | High-Grade Squa... | Data extraction... Immunohistochem... | 18 Years - 35 Years | Brugmann University Hospital | |
| PACE4 in Thyroid Cancer | NCT03160482 | Thyroid Nodule | Immunohistochem... | 18 Years - 100 Years | Université de Sherbrooke | |
| Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma | NCT05889481 | Uveal Melanoma | cytogenetic ana... Digital Patholo... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| HER-2 Expression in Pancreatic Duct Adenocarcinoma | NCT06055647 | Pancreatic Aden... | immunohistochem... | - | Sohag University | |
| Analysis of Tissues From Patients in Trial of Myo-Inositol to Prevent Lung Cancer | NCT00342836 | AKT | Akt levels | 40 Years - 74 Years | National Institutes of Health Clinical Center (CC) | |
| A Prospective Epidemiologic Study of ALK-Positive NSCLC in China | NCT02042105 | Non-small-cell ... | 18 Years - | Guangdong Association of Clinical Trials |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
